STAT3 and neoplasm: Passive accumulation in TME and precise binding of tLyp1 to NRP1 synergistically delivered imatinib into tumour‐infiltrating Treg cells, and their immunosuppressive properties were thwarted by inhibiting the phosphorylation of STAT3 and STAT5.